Main characteristics of hepatocellular carcinoma and cirrhosis and therapeutic approaches

被引:6
|
作者
Elba, S [1 ]
Buongiorno, GP [1 ]
Caruso, ML [1 ]
Noviello, MR [1 ]
Manghisi, OG [1 ]
机构
[1] IRCCS S De Bellis, Serv Radiol, Serv Anat Patol, Div Gastroenterol, Castellana Grotte, Italy
关键词
epidemiology; HCC; ultrasound; histology;
D O I
10.2174/1381612024607027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Between 1995 and 1997 we studied 100 patients with hepatocarcinoma (HCC) and cirrhosis. Of these 74 were males and 26 females with a mean age of 66 years. 13% patients were only HbsAg positive, 75% only anti-HCV positive, 6% HbsAg and anti-HCV and the etiology in 6% of cases was alcoholic. Alpha-foetoprotein was >400ng/ml in only 18% of cases and portal thrombosis was present in 12%. Mononodular HCC was observed in 63% of cases (small HCC in only 38%) and in 79% was localized to the right lobe. Of the mononodular types, 70% were shown by echography to be hypoechoic, 6% hysoechoic, 6% hyperechoic and 17% mixed patterns. Histologically, 49% were well-differentiated, 45% moderately-differentiated and 6% poorly-differentiated. No correlation was found between histologic pattern and number of nodules. Well-differentiated HCC was found in 51% of mononodular types and in 46% of multinodular types. Moderately-differentiated HCC was detected in 46% and 43% respectively and poorly-differentiated HCC in 3% and 11% respectively. No correlation was found between number of nodules and the degree of Edmonson.
引用
收藏
页码:1007 / 1011
页数:5
相关论文
共 50 条
  • [1] Therapeutic approaches to hepatocellular carcinoma
    Borgia, Beatrice
    Neri, Dario
    DRUGS OF THE FUTURE, 2008, 33 (01) : 75 - 83
  • [2] Emerging Therapeutic Approaches to Hepatocellular Carcinoma
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1217 - 1218
  • [3] Emerging Therapeutic Approaches to Hepatocellular Carcinoma
    Timothy M. Pawlik
    Annals of Surgical Oncology, 2010, 17 : 1217 - 1218
  • [4] Multimodal therapeutic approaches for hepatocellular carcinoma
    Bismuth, H
    ZENTRALBLATT FUR CHIRURGIE, 2000, 125 (07): : 647 - 649
  • [5] HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS - THERAPEUTIC POSSIBILITIES
    PORCHERON, J
    CADI, F
    TARDIEU, D
    BALIQUE, JG
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1992, 28 (03): : 131 - 139
  • [6] miRNA in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Approaches
    Qadir, Muhammad Imran
    Rizvi, Samana Zahra
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2017, 27 (04): : 355 - 361
  • [7] Quantitative Approaches to Therapeutic Decision Making in Hepatocellular Carcinoma
    Lee, Steve Y.
    JCO ONCOLOGY PRACTICE, 2021, 17 (04)
  • [8] Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
    Bengtsson, Bonnie
    Stal, Per
    Wahlin, Staffan
    Bjorkstrom, Niklas K.
    Hagstrom, Hannes
    LIVER INTERNATIONAL, 2019, 39 (06) : 1098 - 1108
  • [9] Hepatocellular Carcinoma in Patients Without Cirrhosis - Characteristics, Etiologies and Trends
    Garrido, Isabel
    Pereira, Pedro
    Macedo, Guilherme
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S572 - S573
  • [10] Characteristics of hepatocellular carcinoma in hepatic iron overload without cirrhosis
    Choong, NW
    Brandhagen, DJ
    Roberts, LR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S366 - S366